Skip to main content

Milestone Pharmaceuticals Inc.

MIST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001408443

No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.

13F holders, Q2 2022

Institutional positions in Milestone Pharmaceuticals Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
29
+2 vs. Q1 2022
Shares held
20.8M
−198.7K (−0.9%) vs. Q1 2022
Total value
$127.2M
−$7.81M (−5.8%) vs. Q1 2022
New holders
4
6 more added
Sold out
2
8 more reduced

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting MIST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 29 institutions
Q1 2021: 34 institutionsQ2 2021: 28 institutionsQ3 2021: 27 institutionsQ4 2021: 28 institutionsQ1 2022: 28 institutionsQ2 2022: 29 institutionsQ3 2022: 47 institutionsQ4 2022: 56 institutionsQ1 2023: 50 institutionsQ2 2023: 48 institutionsQ3 2023: 39 institutionsQ4 2023: 40 institutionsQ1 2024: 43 institutionsQ2 2024: 40 institutionsQ3 2024: 43 institutionsQ4 2024: 47 institutionsQ1 2025: 43 institutionsQ2 2025: 43 institutionsQ3 2025: 61 institutionsQ4 2025: 80 institutionsQ1 2026: 87 institutionsQ2 2026: 78 institutions
Value heldQ2 2022: $127.2M
Q1 2021: $117.4MQ2 2021: $110.8MQ3 2021: $113.9MQ4 2021: $132.6MQ1 2022: $135.1MQ2 2022: $127.2MQ3 2022: $198.7MQ4 2022: $96.9MQ1 2023: $85.5MQ2 2023: $59.0MQ3 2023: $60.7MQ4 2023: $29.7MQ1 2024: $56.4MQ2 2024: $39.9MQ3 2024: $43.6MQ4 2024: $57.9MQ1 2025: $9.46MQ2 2025: $22.9MQ3 2025: $68.3MQ4 2025: $70.7MQ1 2026: $47.2MQ2 2026: $66.4M
Institutions holding MIST and their total value by quarter
QuarterHoldersValue
Q2 202678$66.4M
Q1 202687$47.2M
Q4 202580$70.7M
Q3 202561$68.3M
Q2 202543$22.9M
Q1 202543$9.46M
Q4 202447$57.9M
Q3 202443$43.6M
Q2 202440$39.9M
Q1 202443$56.4M
Q4 202340$29.7M
Q3 202339$60.7M
Q2 202348$59.0M
Q1 202350$85.5M
Q4 202256$96.9M
Q3 202247$198.7M
Q2 202229$127.2M
Q1 202228$135.1M
Q4 202128$132.6M
Q3 202127$113.9M
Q2 202128$110.8M
Q1 202134$117.4M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Milestone Pharmaceuticals Inc.; share changes are against Q1 2022.

Institutions holding MIST in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
RTW Investments, LP4,315,102$26.5M0.69%00.0%Unchanged
Novo Holdings A/S2,530,003$15.6M0.77%00.0%Unchanged
Ra Capital Management, L.P.2,246,503$13.8M0.37%00.0%Unchanged
Boxer Capital, LLC2,238,861$13.8M0.87%00.0%Unchanged
OrbiMed Advisors LLC1,817,521$11.2M0.22%−766,300−29.7%Reduced
Ikarian Capital, LLC1,379,422$8.19M3.40%−549,330−28.5%Reduced
Morgan Stanley1,318,173$8.11M0.00%+499,533+61.0%Added
Millennium Management LLC1,358,362$8.07M0.01%+69,439+5.4%Added
Pura Vida Investments, LLC987,411$6.07M0.97%00.0%Unchanged
Lion Point Capital, LP948,570$5.63M2.00%+265,000+38.8%Added
Bleichroeder LP512,500$3.04M0.63%+262,500+105.0%Added
Acuta Capital Partners, LLC457,200$2.81M1.57%+77,200+20.3%Added
Barclays PLC211,710$1.30M0.00%−15,000−6.6%Reduced
Eversept Partners, LP147,165$905.1K0.09%00.0%Unchanged
Boothbay Fund Management, LLC132,501$815.0K0.03%−51,697−28.1%Reduced
Dimensional Fund Advisors LP75,346$448.0K0.00%+13,603+22.0%Added
State Street Corp21,608$128.0K0.00%−194−0.9%Reduced
Royal Bank of Canada18,500$114.0K0.00%−8,002−30.2%Reduced
Susquehanna International Group, LLP18,233$108.0K0.00%+18,233New
Geode Capital Management, LLC17,576$104.0K0.00%00.0%Unchanged
National Bank of Canada14,842$88.0K0.00%00.0%Unchanged
Acadian Asset Management LLC13,717$84.0K0.00%−5,553−28.8%Reduced
Goldman Sachs Group Inc12,004$74.0K0.00%00.0%Unchanged
LMR Partners LLP11,732$72.0K0.00%+11,732New
Federation des caisses Desjardins du Quebec10,500$64.6K0.00%00.0%Unchanged
JPMorgan Chase & Co3,539$21.0K0.00%−10,041−73.9%Reduced
Urban Wealth Management, LLC3,194$20.0K0.07%+3,194New
Advisor Group Holdings, Inc.2,879$18.0K0.00%00.0%Unchanged
UBS Group AG1,016$6.00K0.00%+1,016New
PDT Partners, LLC0$00.00%−10,165−100.0%Sold out
BNP Paribas Arbitrage, SA0$00.00%−3,848−100.0%Sold out
Susquehanna Fundamental Investments, LLC––––Not filed